Automation of the glycerolization of red blood cells with the high‐separation bowl in the Haemonetics ACP 215 instrument
- 19 September 2005
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 45 (10) , 1621-1627
Abstract
BACKGROUND: The FDA has approved a closed‐system red blood cell (RBC) glycerolization procedure with the ACP 215 (Haemonetics), which requires a centrifuge to prepare RBCs before and after glycerolization. In the study reported here, the Haemonetics high‐separation bowl was evaluated in an attempt to automate these two concentration steps.STUDY DESIGN AND METHODS: Ten units of nonleukoreduced citrate phosphate dextrose (CPD)‐anticoagulated whole blood were stored at 4°C for 2 to 6 days before glycerolization and freezing as nonrejuvenated RBCs. Twenty‐five units of nonleukoreduced CPD whole blood were stored at 4°C for 2 to 8 days and then biochemically treated with a solution containing pyruvate, inosine, phosphate, and adenine (PIPA) before glycerolization and freezing as indated‐rejuvenated RBC. Twenty units of leukoreduced CPD and AS‐1 RBCs were stored at 4°C for a mean of 48 days and treated with PIPA solution before glycerolization and freezing as outdated‐rejuvenated RBCs. The glycerolized RBCs were frozen for at least 2 weeks at −80°C, deglycerolized in the Haemonetics ACP 215 with the 325‐mL bowl, and stored in AS‐3 at 4°C for 21 days.RESULTS: It took approximately 50 minutes to glycerolize the nonrejuvenated and rejuvenated RBCs. After freezing, deglycerolization, and postwash storage at 4°C in AS‐3 for 2 weeks, the quality was similar to that of RBCs processed by the current FDA‐approved method.CONCLUSION: Processing time and need for technical expertise were significantly reduced with the completely automated functionally closed glycerolization procedure with the high‐separation bowl in the Haemonetics ACP 215 instrument.Keywords
This publication has 12 references indexed in Scilit:
- Extended storage of AS‐1 and AS‐3 leukoreduced red blood cells for 15 days after deglycerolization and resuspension in AS‐3 using an automated closed systemTransfusion, 2004
- The in vitro quality of red blood cells frozen with 40 percent (wt/vol) glycerol at −80°C for 14 years, deglycerolized with the Haemonetics ACP 215, and stored at 4°C in additive solution‐1 or additive solution‐3 for up to 3 weeksTransfusion, 2004
- In vivo survival of apheresis RBCs, frozen with 40‐percent (wt/vol) glycerol, deglycerolized in the ACP 215, and stored at 4°C in AS‐3 for up to 21 daysTransfusion, 2001
- A multicenter study of in vitro and in vivo values in human RBCs frozen with 40‐percent (wt/vol) glycerol and stored after deglycerolization for 15 days at 4°C in AS‐3: assessment of RBC processing in the ACP 215Transfusion, 2001
- The survival, function, and hemolysis of human RBCs stored at 4°C in additive solution (AS‐1, AS‐3, or AS‐5) for 42 days and then biochemically modified, frozen, thawed, washed, and stored at 4°C in sodium chloride and glucose solution for 24 hoursTransfusion, 2000
- A survey of more than 90 commercially available luminometers and imaging devices for low‐light measurements of chemiluminescence and bioluminescence, including instruments for manual, automatic and specialized operation, for HPLC, LC, GLC and microtitre plates. Part 1: DescriptionsJournal of Bioluminescence and Chemiluminescence, 1992
- Freezing in the Primary Polyvinylchloride Plastic Collection Bag: A New System for Preparing and Freezing Nonrejuvenated and Rejuvenated Red Blood CellsTransfusion, 1981
- A spectrophotometric scanning technique for the rapid determination of plasma hemoglobinClinical Biochemistry, 1975
- Rejuvenation and Freezing of Outdated Stored Human Red CellsNew England Journal of Medicine, 1972
- Comparison of the Effects of Ionic and Non‐ionic Solutions on the Volume and Intracellular Potassium of Frozen and Non‐frozen Human Red CellsTransfusion, 1968